Real-world treatment patterns and outcomes by mismatch repair/microsatellite instability (MMR/MSI) status in patients (pts) with advanced endometrial cancer (aEC), 2018-2023.

被引:0
|
作者
Pothuri, Bhavana
Thaker, Premal H.
Tymejczyk, Olga
Reiss, Samantha
Nitti, Giovanni
Cain, Theresa
Hada, Manila
机构
[1] NYU Langone Hlth, Div Gynecol Oncol, Dept Obstet & Gynecol, New York, NY USA
[2] Washington Univ, Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol, St Louis, MO 63110 USA
[3] Flatiron Hlth Inc, New York, NY USA
[4] AstraZeneca, Gaithersburg, MD USA
[5] AstraZeneca, Cambridge, England
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5601
引用
收藏
页数:1
相关论文
共 50 条
  • [11] Nationwide Real-World Data of Microsatellite Instability and/or Mismatch Repair Deficiency in Cancer: Prevalence and Testing Patterns
    Fountzilas, Elena
    Papadopoulos, Theofanis
    Papadopoulou, Eirini
    Gouedard, Cedric
    Kourea, Helen P.
    Constantoulakis, Pantelis
    Magkou, Christina
    Sfakianaki, Maria
    Kotoula, Vassiliki
    Bantouna, Dimitra
    Raptou, Georgia
    Saetta, Angelica A.
    Christopoulou, Georgia
    Hatzibougias, Dimitris
    Michalopoulou-Manoloutsiou, Electra
    Siatra, Eleni
    Eleftheriadis, Eleftherios
    Kavoura, Evangelia
    Kaklamanis, Loukas
    Sourla, Antigoni
    Papaxoinis, George
    Pavlakis, Kitty
    Hytiroglou, Prodromos
    Vourlakou, Christina
    Arapantoni-Dadioti, Petroula
    Murray, Samuel
    Nasioulas, George
    Timologos, Grigorios
    Fountzilas, George
    Saridaki, Zacharenia
    DIAGNOSTICS, 2024, 14 (11)
  • [12] KNOWLEDGE AND AWARENESS OF MISMATCH REPAIR/MICROSATELLITE INSTABILITY (MMR/MSI) TESTING AMONG US PATIENTS WITH ADVANCED/METASTATIC COLORECTAL CANCER (MCRC)
    Eriksson, J.
    Amonkar, M.
    Al-Jassar, G.
    Lambert, J.
    Malmenas, M.
    Chase, M.
    Sun, L.
    Kollmar, L.
    Vichnin, M.
    VALUE IN HEALTH, 2019, 22 : S110 - S110
  • [13] Real-world prevalence of microsatellite instability testing and related status in women with advanced endometrial cancer in Europe
    Kelkar, Sneha S.
    Prabhu, Vimalanand S.
    Zhang, Jingchuan
    Ogando, Yoscar M.
    Roney, Kyle
    Verma, Rishi P.
    Miles, Nicola
    Marth, Christian
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2024, 309 (06) : 2833 - 2841
  • [14] Real-world study on microsatellite instability and mismatch repair deficiency testing patterns among patients with metastatic colorectal cancer in Spain
    Garcia-Carbonero, Rocio
    Gonzalez Astorga, Beatriz
    Vidal Tocino, Rosario
    Contreras Toledo, Debora
    Pericay, Carles
    Fernandez Montes, Ana
    Falco, Esther
    Gonzalez Cordero, Marta
    Zoilo, Juan Jose Reina
    Alonso, Vicente
    Salas, Nuria Rodriguez
    Gil-Raga, Mireia
    Santos, Cristina
    Paez, David
    Anton-Pascual, Beatriz
    Aguilar, Fernando
    Morales, Pilar
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 26 (4): : 864 - 871
  • [15] Real-world study on microsatellite instability and mismatch repair deficiency testing patterns among patients with metastatic colorectal cancer in Spain
    Rocio Garcia-Carbonero
    Beatriz González Astorga
    Rosario Vidal Tocino
    Débora Contreras Toledo
    Carles Pericay
    Ana Fernández Montes
    Esther Falcó
    Marta González Cordero
    Juan José Reina Zoilo
    Vicente Alonso
    Nuria Rodríguez Salas
    Mireia Gil-Raga
    Cristina Santos
    David Páez
    Beatriz Anton-Pascual
    Fernando Aguilar
    Pilar Morales
    Clinical and Translational Oncology, 2024, 26 : 864 - 871
  • [16] Microsatellite instability (MSI), mismatch repair (MMR), and tumor mutational burden (TMB) as predictive biomarkers for immune checkpoint inhibitor (ICI) effectiveness in real-world patients with metastatic colorectal cancer (mCRC).
    Ellis, Haley
    Klempner, Samuel J.
    Quintanilha, Julia C. F. C. F.
    Myer, Parvathi
    Lin, Douglas I.
    Panarelli, Nicole
    Fisher, Virginia
    Li, Gerald
    Huang, Richard S. P.
    Ross, Jeffrey S.
    Oxnard, Geoffrey R.
    Graf, Ryon
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 46 - 46
  • [17] Real-world prevalence of microsatellite instability testing and related status in women with advanced endometrial cancer in the United States
    Kelkar, Sneha
    Macahilig, Cynthia
    Zhang, Jingchuan
    Prabhu, Vimalanand
    Odak, Shardul
    Rusibamayila, Nifasha
    Corman, Shelby
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S258 - S258
  • [18] Real-world first-line treatment patterns and outcomes in recurrent/advanced endometrial cancer patients in Europe
    Zhang, Jingchuan
    Kelkar, Sneha S.
    Prabhu, Vimalanand S.
    Ogando, Yoscar M.
    Verma, Rishi P.
    Grall, Veronique
    Marth, Christian
    FUTURE ONCOLOGY, 2024,
  • [19] Immunotherapy in advanced mismatch repair deficiency endometrial cancer: A real-world single center experience
    Rauthan, A.
    Murthy, N. Y.
    Patil, P.
    Prasannakumar, S. Sampige
    Zaveri, S.
    Ashwath, R.
    Vundemodalu, P.
    Jomi, C.
    ANNALS OF ONCOLOGY, 2022, 33 : S1513 - S1513
  • [20] Activity of durvalumab in advanced endometrial cancer (AEC) according to mismatch repair (MMR) status: The phase II PHAEDRA trial (ANZGOG1601).
    Antill, Yoland Catherine
    Kok, Peey Sei
    Robledo, Kristy
    Barnes, Elizabeth
    Friedlander, Michael
    Baron-Hay, Sally E.
    Shannon, Catherine M.
    Coward, Jermaine
    Beale, Philip James
    Goss, Geraldine
    Meniawy, Tarek
    Yip, Sonia
    Smith, Deborah
    Spurdle, Amanda B.
    Parry, Michelle
    Andrews, John
    Kelly, Marzena
    Stockler, Martin R.
    Mileshkin, Linda R.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)